20 LATEST RESOURCES (88 INDEXED)
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial · November 2023
Abstracts
Journal of the American Medical Association
The Real-World Effectiveness of Fluvoxamine Therapy in Mild to Moderate COVID-19 Patients; A Historical Cohort Study (Fluvoxa Trial) · October 2023
Articles
Journal of Infection and Public Health
Effect of Fluvoxamine on Plasma Interleukin-6 in Patients with Major Depressive Disorder: A Prospective Follow-Up Study · May 2023
Articles
Frontiers in Psychiatry
Infant Exposure to Fluvoxamine through Placenta and Human Milk: A Case Series – A Contribution from the ConcePTION Project · May 2023
Articles
Frontiers in Psychiatry
Overview of the Potential Use of Fluvoxamine for COVID-19 and Long COVID · March 2023
Articles
Discover Mental Health
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial · January 2023
Multimedia (Interviews-Authors)
Journal of the American Medical Association
Impact of Fluvoxamine on Outpatient Treatment of COVID-19 in Honduras in a Prospective Observational Real-World Study · November 2022
Articles
Frontiers in Pharmacology
Effect of Fluvoxamine on Outcomes of Nonhospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis · October 2022
Articles
Journal of Infection and Public Health
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study · October 2022
Articles
Primary Care Companion for CNS Disorders
Fluvoxamine for the Treatment of COVID-19 · September 2022
Articles
Cochrane Database of Systematic Reviews
Pharmacogenetic Aspects of COVID-19 Management and Post-COVID-19 Depression Treatment with Fluvoxamine · September 2022
Articles
NCBI>Psychiatria Danubina
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 · August 2022
Articles
New England Journal of Medicine
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-Analysis · April 2022
Articles
JAMA Network Open
Effect of Sertraline and Fluvoxamine on Quality of Life in Patients with Obsessive-Compulsive Disorder: A 12-Week Interventional Study · March 2022
Articles
Industrial Psychiatry Journal
Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention · December 2021
Articles
Current Neuropharmacology
Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants · December 2021
Articles
Frontiers in Pharmacology
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence · December 2021
Articles
Drugs
Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalisation among Patients with COVID-19: The TOGETHER Randomised, Platform Clinical Trial · October 2021
Articles
Lancet Global Health
Retrospective Review of Fluvoxamine-Clomipramine Combination Therapy in Obsessive-Compulsive Disorder in Children and Adolescents · August 2021
Articles
NCBI>Journal of the Canadian Academy of Child and Adolescent Psychiatry
Successful Combination Therapy of Trazodone and Fluvoxamine for Pica in Alzheimer’s Disease: A Case Report · July 2021
Articles
Frontiers in Psychiatry